Medbright Ai Invts Inc.

As of May 31, 2025, Medbright Ai Invts Inc. has 110.37M shares outstanding.

As of May 31, 2025, Medbright Ai Invts Inc. trades at a trailing price-to-earnings ratio of 11.33.

As of May 31, 2025, Medbright Ai Invts Inc. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.77, indicating moderate leverage, while an interest coverage ratio of -4,033.46 demonstrates limited ability to service its debt obligations.

Over the twelve months ended May 31, 2025, Medbright Ai Invts Inc. posted a negative return on equity (ROE) of -49.71, meaning shareholder capital produced losses rather than profits. Return on invested capital (ROIC) is negative at -29.55, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 21.10, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is negative at -36.08, pointing to unprofitable operations over the period.

These figures cover the twelve months ended May 31, 2025. Free cash flow yield is negative at -7.30: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.31, meaning Medbright Ai Invts Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Medbright Ai Invts Inc.'s most recent stock split took place on May 19, 2023 with a 5:1 split ratio.

As of May 31, 2025, Medbright Ai Invts Inc. has an Altman Z-Score of -2.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.